2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema

[1]  K. Kragballe,et al.  Hereditary Angioedema. , 2018, The New England journal of medicine.

[2]  K. Bork,et al.  25 years of safety experience with C1 inhibitor concentrate in treatment of acute hereditary angioedema attacks , 2011 .

[3]  K. Ker,et al.  Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. , 2011, The Cochrane database of systematic reviews.

[4]  M. Magerl,et al.  Successful treatment of an acute attack of acquired angioedema with the bradykinin‐B2‐receptor antagonist icatibant , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[5]  D. Johnston.  Diagnosis and Management of Hereditary Angioedema , 2011, The Journal of the American Osteopathic Association.

[6]  J. Cesbron,et al.  Type III hereditary angio‐oedema: clinical and biological features in a French cohort , 2010, Allergy.

[7]  T. Klingebiel,et al.  Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate. , 2010, American journal of obstetrics and gynecology.

[8]  B. Zuraw.  HAE therapies: past present and future , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[9]  T. Klingebiel,et al.  On demand treatment and home therapy of hereditary angioedema in Germany - the Frankfurt experience , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[10]  K. Bork.  Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[11]  H. Farkas,et al.  Management of upper airway edema caused by hereditary angioedema , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[12]  K. Binkley.  ALLERGY, ASTHMA & CLINICAL IMMUNOLOGY REVIEW Open Access Factor XII mutations, estrogen-dependent , 2022 .

[13]  H. Farkas.  Pediatric hereditary angioedema due to C1-inhibitor deficiency , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[14]  L. Bouillet.  Hereditary angioedema in women , 2010, Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology.

[15]  M. Gompels,et al.  HAE international home therapy consensus document , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[16]  B. Ritchie,et al.  Management of hereditary angioedema: 2010 Canadian approach , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[17]  T. Craig,et al.  Treatment of Hereditary Angioedema: items that need to be addressed in practice parameter , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[18]  P. Pundir,et al.  Comparison of the inhibitory effects of resveratrol and tranilast on IgE, 48/80 and substance P dependent-mast cell activation , 2010, Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology.

[19]  J. Cesbron,et al.  Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks. , 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[20]  J. Bernstein,et al.  Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. , 2009, The Journal of allergy and clinical immunology.

[21]  T. Klingebiel,et al.  C1‐inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis , 2009, Transfusion.

[22]  K. Bork,et al.  Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy. , 2009, The Journal of allergy and clinical immunology.

[23]  T. Craig,et al.  When is prophylaxis for hereditary angioedema necessary? , 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[24]  G. Blohmé.  Treatment of hereditary angioneurotic oedema with tranexamic acid. A random double-blind cross-over study. , 2009 .

[25]  A. Szema,et al.  Modern preoperative and intraoperative management of hereditary angioedema. , 2009, Allergy and asthma proceedings.

[26]  Jason J. Howard,et al.  Perioperative Blood Transfusion Requirements in Pediatric Scoliosis Surgery: The Efficacy of Tranexamic Acid , 2009, Journal of pediatric orthopedics.

[27]  K. Andersen,et al.  Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits. , 2009, European journal of dermatology : EJD.

[28]  A. Schouten,et al.  The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: A meta-analysis , 2009, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[29]  L. Alfredsson,et al.  The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case–control study using the General Practice Research Database , 2009, BJOG : an international journal of obstetrics and gynaecology.

[30]  J. Kastelein,et al.  Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema. , 2008, Clinical therapeutics.

[31]  H. Farkas,et al.  Disease expression in women with hereditary angioedema. , 2008, American journal of obstetrics and gynecology.

[32]  H. Joller-jemelka,et al.  Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations. , 2008, Journal of immunological methods.

[33]  K. Bork,et al.  Treatment of skin swellings with C1‐inhibitor concentrate in patients with hereditary angio‐oedema , 2008, Allergy.

[34]  M. Frank.  8. Hereditary angioedema. , 2008, The Journal of allergy and clinical immunology.

[35]  K. Bork,et al.  Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[36]  H. Farkas,et al.  Management of Hereditary Angioedema in Pediatric Patients , 2007, Pediatrics.

[37]  K. Khair,et al.  C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option , 2006, Clinical and experimental immunology.

[38]  M. Cicardi,et al.  Angioedema without urticaria: a large clinical survey , 2006, Canadian Medical Association Journal.

[39]  T. Bowen.  Angioedema and the Canadian Network of Rare Blood Disorder Organizations: extending the Canadian hemophilia care model , 2006, Canadian Medical Association Journal.

[40]  M. Levi,et al.  Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. , 2006, The Journal of allergy and clinical immunology.

[41]  K. Bork,et al.  Hereditary angioedema: new findings concerning symptoms, affected organs, and course. , 2006, The American journal of medicine.

[42]  A. Eckardt,et al.  Symptoms, Course, and Complications of Abdominal Attacks in Hereditary Angioedema Due to C1 Inhibitor Deficiency , 2006, The American Journal of Gastroenterology.

[43]  K. Bork,et al.  Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema , 2005, Transfusion.

[44]  M. Tang,et al.  Hereditary angio‐oedema in children: A management guideline , 2005, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[45]  M. Gompels,et al.  C1 inhibitor deficiency: consensus document , 2005, Clinical and experimental immunology.

[46]  William H. Yang,et al.  Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema. , 2004, The Journal of allergy and clinical immunology.

[47]  A. Tordai,et al.  Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond , 2004, Journal of Allergy and Clinical Immunology.

[48]  M. Colombo,et al.  Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. , 2004, Gastroenterology.

[49]  Zhao-You Tang,et al.  Randomized controlled trial of screening for hepatocellular carcinoma , 2004, Journal of Cancer Research and Clinical Oncology.

[50]  M. Cicardi,et al.  C1 inhibitor concentrate therapy in 473 patients with hereditary and acquired angioedema , 2004 .

[51]  D. Parkin,et al.  Screening for liver cancer: results of a randomised controlled trial in Qidong, China , 2003, Journal of medical screening.

[52]  K. Bork,et al.  Sudden upper airway obstruction in patients with hereditary angioedema. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[53]  J. Lindner,et al.  Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert® P) in hereditary angioedema: a review , 2003 .

[54]  H. Farkas,et al.  The Hungarian HAE experience. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[55]  William H. Yang,et al.  Management of hereditary angioedema: a Canadian approach. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[56]  V. Chen,et al.  Screening for Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis: A Cost-Utility Analysis , 2003, American Journal of Gastroenterology.

[57]  K. Bork,et al.  Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. , 2003, The American journal of medicine.

[58]  M. Leahy,et al.  Pulmonary embolism associated with tranexamic acid in severe acquired haemophilia , 2002, European journal of haematology.

[59]  K. Bork,et al.  Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema. , 2002, Journal of hepatology.

[60]  H. Farkas,et al.  Erythema marginatum preceding an acute oedematous attack of hereditary angioneurotic oedema. , 2001, Acta dermato-venereologica.

[61]  H. Farkas,et al.  Ultrasonography in the diagnosis and monitoring of ascites in acute abdominal attacks of hereditary angioneurotic oedema , 2001, European journal of gastroenterology & hepatology.

[62]  S. Lethagen,et al.  No Increased Risk of Venous Thrombosis in Women Taking Tranexamic Acid , 2001, Thrombosis and Haemostasis.

[63]  G. Watanabe,et al.  Effect of tranexamic acid on blood loss reduction after cardiopulmonary bypass. , 2001, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

[64]  D. Brettler,et al.  Home‐based factor infusion therapy and hospitalization for bleeding complications among males with haemophilia , 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

[65]  K. Bork,et al.  Hereditary angioedema with normal C1-inhibitor activity in women , 2000, The Lancet.

[66]  J. Hammer,et al.  A vote for inhaled adrenaline in the treatment of severe upper airway obstruction caused by piercing of the tongue in hereditary angioedema , 1999, Intensive Care Medicine.

[67]  A. Saincher.  A Canadian approach , 1999 .

[68]  K. Bork,et al.  Hepatocellular adenomas in patients taking danazol for here ditary angiooedema , 1999, The Lancet.

[69]  C. Létoublon,et al.  Danazol therapy: an unusual aetiology of hepatocellular carcinoma. , 1998, Journal of hepatology.

[70]  M. Cicardi,et al.  Pathogenetic and clinical aspects of C1 inhibitor deficiency. , 1998, Immunobiology.

[71]  F. Rosen,et al.  A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema , 1998, Transfusion.

[72]  M. Cicardi,et al.  Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. , 1997, The Journal of allergy and clinical immunology.

[73]  F. Rosen,et al.  Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. , 1996, The New England journal of medicine.

[74]  T. Strine,et al.  Changes in longevity and causes of death among persons with hemophilia A , 1994, American journal of hematology.

[75]  T. Mollnes,et al.  C1 Inhibitor and Diagnosis of Hereditary Angioedema in Newborns , 1994, Pediatric Research.

[76]  C. Lindoff,et al.  Treatment with Tranexamic Acid during Pregnancy, and the Risk of Thrombo-Embolic Complications , 1993, Thrombosis and Haemostasis.

[77]  M. Cicardi,et al.  Hereditary and Acquired C1‐Inhibitor Deficiency: Biological and Clinical Characteristics in 235 Patients , 1992, Medicine.

[78]  E. Hack,et al.  Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience. , 1991, The Journal of allergy and clinical immunology.

[79]  B. Brenner,et al.  Angioedema during therapy with recombinant tissue plasminogen activator. , 1991, British journal of haematology.

[80]  M. Frank,et al.  Oral manifestations and dental management of patients with hereditary angioedema. , 1991, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[81]  K. Whaley,et al.  Regional assignment of the human C1-inhibitor gene to 11q11–q13.1 , 1990, Human Genetics.

[82]  K. Woo,et al.  Massive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapy , 1989, The British journal of clinical practice.

[83]  R. T. Wall,et al.  A review of 25 patients with hereditary angioedema requiring surgery. , 1989, Anesthesiology.

[84]  M. Blombäck,et al.  Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery. , 1989, The New England journal of medicine.

[85]  A. Miura,et al.  Deep-vein thrombosis induced by tranexamic acid in idiopathic thrombocytopenic purpura. , 1988, JAMA.

[86]  J. Curd,et al.  The value of rocket immunoelectrophoresis for C4 activation in the evaluation of patients with angioedema or C1-inhibitor deficiency. , 1986, The Journal of allergy and clinical immunology.

[87]  R. Huber,et al.  Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization. , 1986, Biochemistry.

[88]  P. Theil,et al.  OPHTHALMOLOGICAL EXAMINATION OF PATIENTS IN LONG‐TERM TREATMENT WITH TRANEXAMIC ACID , 1981, Acta ophthalmologica.

[89]  K. Ishak,et al.  HEPATIC ANGIOSARCOMA ASSOCIATED WITH ANDROGENIC-ANABOLIC STEROIDS , 1979, The Lancet.

[90]  D. Alling,et al.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. , 1976, The New England journal of medicine.

[91]  S. E. Levin,et al.  Occurrence of primary hepatocellular cancer and peliosis hepatis after treatment with androgenic steroids. , 1976, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[92]  J. Atkinson,et al.  Hereditary angioedema: the clinical syndrome and its management. , 1976, Annals of internal medicine.

[93]  J. Atkinson,et al.  Hereditary angioedema: the use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery. , 1975, The Journal of allergy and clinical immunology.

[94]  H. Strawczynski,et al.  Delivery of care to hemophilic children: home care versus hospitalization. , 1973, Pediatrics.

[95]  P. Schur,et al.  Acquired C1 inhibitor deficiency in lymphosarcoma , 1972 .

[96]  D. Alling,et al.  Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study. , 1972, The New England journal of medicine.

[97]  R. R. Evans,et al.  A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. , 1963, The American journal of medicine.

[98]  K. Ker,et al.  Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. , 2011, The Cochrane database of systematic reviews.

[99]  O. Fain.  [Acquired angioedema]. , 2010, La Revue de medecine interne.

[100]  Meral Günaldı,et al.  Acute myocardial infarction in a patient with hemophilia A and factor V Leiden mutation. , 2009, Cardiology journal.

[101]  B. Wedi,et al.  Allergy, Asthma & Clinical Immunology , 2009 .

[102]  A. Sheffer,et al.  Hereditary angioedema: a current state-of-the-art review, V: attenuated androgens for the treatment of hereditary angioedema. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[103]  William H. Yang,et al.  Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[104]  I. Bernstein,et al.  Hereditary angioedema: a current state-of-the-art review, II: historical perspective of non-histamine-induced angioedema. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[105]  A. Davis.  Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[106]  B. Zuraw.  Hereditary angiodema: a current state-of-the-art review, IV: short- and long-term treatment of hereditary angioedema: out with the old and in with the new? , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[107]  J. Bernstein.  Hereditary angioedema: a current state-of-the-art review, VIII: current status of emerging therapies. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[108]  K. Goa,et al.  Tranexamic acid: a review of its use in surgery and other indications. , 1999, Drugs.

[109]  J. Souto,et al.  Oral surgery in anticoagulated patients without reducing the dose of oral anticoagulant: a prospective randomized study. , 1996, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[110]  G. Ewald,et al.  Plasmin-mediated activation of contact system in response to pharmacological thrombolysis. , 1995, Circulation.

[111]  G. Andriole,et al.  Danazol-induced cystitis: an undescribed source of hematuria in patients with hereditary angioneurotic edema. , 1986, The Journal of urology.

[112]  M. Cicardi,et al.  Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema. , 1980, The Journal of allergy and clinical immunology.

[113]  D. Alling,et al.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. , 1976, The New England journal of medicine.